Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infection

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc..

Regulatory T (Treg) cell modulation of adaptive immunity and tissue homeostasis is well described; however, less is known about Treg cell-mediated regulation of the innate immune response. Here we show that deletion of ST2, the receptor for interleukin (IL)-33, on Treg cells increased granulocyte influx into the lung and increased cytokine production by innate lymphoid and γδ T cells without alteration of adaptive immunity to influenza. IL-33 induced high levels of the interleukin-1 receptor antagonist (IL-1Ra) in ST2+ Treg cells and deletion of IL-1Ra in Treg cells increased granulocyte influx into the lung. Treg cell-specific deletion of ST2 or IL-1Ra improved survival to influenza, which was dependent on IL-1. Adventitial fibroblasts in the lung expressed high levels of the IL-1 receptor and their chemokine production was suppressed by Treg cell-produced IL-1Ra. Thus, we define a new pathway where IL-33-induced IL-1Ra production by tissue Treg cells suppresses IL-1-mediated innate immune responses to respiratory viral infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Nature immunology - 24(2023), 12 vom: 09. Dez., Seite 2091-2107

Sprache:

Englisch

Beteiligte Personen:

Griffith, Jason W [VerfasserIn]
Faustino, Lucas D [VerfasserIn]
Cottrell, Victoria I [VerfasserIn]
Nepal, Keshav [VerfasserIn]
Hariri, Lida P [VerfasserIn]
Chiu, Rebecca Suet-Yan [VerfasserIn]
Jones, Michael C [VerfasserIn]
Julé, Amélie [VerfasserIn]
Gabay, Cem [VerfasserIn]
Luster, Andrew D [VerfasserIn]

Links:

Volltext

Themen:

Il1rn protein, mouse
Interleukin 1 Receptor Antagonist Protein
Interleukin-1
Interleukin-1 Receptor-Like 1 Protein
Interleukin-33
Journal Article

Anmerkungen:

Date Completed 05.12.2023

Date Revised 06.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41590-023-01655-2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364375299